TIESHA PANEK: Open Payments
NPI 1477250595 · CARY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,120 in 48 payments from 13 companies in 2025. Trend: 2023 $1,508 · 2024 $2,303 · 2025 $1,120
Food & beverage: $1,120
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $279 |
| Axsome Therapeutics, Inc. | 6 | $189 |
| Otsuka America Pharmaceutical, Inc. | 6 | $146 |
| E.R. Squibb & Sons, L.L.C. | 3 | $81 |
| HARMONY BIOSCIENCES LLC | 2 | $80 |
| Neurocrine BioSciences, Inc. | 3 | $79 |
| Lundbeck LLC | 3 | $78 |
| Alkermes, Inc. | 3 | $67 |
| Teva Pharmaceuticals USA, Inc. | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: VRAYLAR, REXULTI, Auvelity, COBENFY, WAKIX, INGREZZA, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across IL — which companies pay providers there.
